3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol,
linsitinib,
OSI 906,
OSI-906,
OSI906,
Linsitinib,
867160-71-2,
OSI-906,
Linsitinib(OSI-906),
OSI906,
OSI 906,
OSI-906AA,
OSI-906 (Linsitinib),
UNII-15A52GPT8T,
Kinome_3532,
ASP-7487,
3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol,
15A52GPT8T,
CHEMBL1091644,
MMV676605,
cis-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol,
C26H23N5O,
cis-3-(8-amino-1-(2-phenyl-7-quinolinyl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol,
Linsitinib [USAN:INN],
OSI906/Linsitinib/,
Linsitinib; OSI-906,
Linsitinib (USAN/INN),
Linsitinib (OSI-906),
MLS006010304,
SCHEMBL400369,
SCHEMBL400734,
SCHEMBL400735,
GTPL7423,
CHEMBL1996234,
SCHEMBL10255925,
CHEBI:91402,
EX-A719,
QCR-128,
BCPP000137,
BDBM185150,
HMS3654C19,
AOB87170,
BCP01831,
KS-00000T7A,
ABP000779,
BDBM50315887,
MFCD12912153,
s1091,
ZINC53239527,
AKOS024464740,
ZINC100071817,
ZINC113742575,
BCP9001035,
CS-0242,
PB22643,
RL05373,
NCGC00250375-02,
NCGC00250375-14,
AC-26953,
AK176016,
AS-16999,
BC638839,
HY-10191,
SC-95136,
SMR004700744,
FT-0670821,
SW218150-2,
X7473,
D09925,
W-5542,
J-520074,
BRD-K07667918-001-01-3,
OSI-906, 867160-71-2,
(1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol,
3-(8-amino-1-(2-phenylquinolin-7-yl)-2,3-dihydroimidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol,
3-[8-AMINO-1-(2-PHENYL-QUINOLIN-7-YL)-IMIDAZO[1,5-A]PYRAZIN-3-YL]-1-METHYL-CYCLOBUTANOL,
Linsitinib [USAN],
OSI-906 Linsitinib,
D01GFX,
cc-217,
C26-H23-N5-O,
CID11640390,
CID 11640390,
A8334,
A11053,
C551528,
(1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol,
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol,